-
Adhere to the people as the center and vigorously develop the food and drug industry of the same origin
Time of Update: 2022-08-30
The "Opinions on Further Promoting the Development of the Agricultural Products Processing Industry" (Guobanfa (2016) No. 93) issued by the General Office of the State Council clearly stated that "focusing on supporting research on the extraction technology of nutritious and functional components such as fruits, vegetables, tea, fungi and Chinese medicinal materials, Develop processed foods with balanced nutrition, health care, and the same origin of food and medicine .
-
Southwest China is the origin and domestication center of tartary buckwheat in the world
Time of Update: 2021-07-22
The study also identified independent domestication intervals and important genetic loci related to agronomic and quality traits such as plant height, thousand-grain weight, peel color, and flavonoid content in the two cultivated populations of tartary buckwheat; at the same time, it also analyzed and mined the use of GWAS The key regulatory genes of rutin and other important active substances have been functionally analyzed .
-
Donghua original automated frying center, the beginning of a new era of intelligent pharmaceutical
Time of Update: 2020-12-12
pharmacy automation, to provide a one-stop service Donghuayuan modern frying center using The Internet control system integrated technology to achieve automatic frying production line frying process control automation, automatic access, intelligent transfer, intelligent transmission, intelligent cooking, automatic packaging, intelligent subcontract palletizing really realized from the review party, Traditional Chinese medicine preparations, paste production to packaging products of pharmaceutical intelligence.
-
JNNP: The Origin of Seizures of Autoimmune Diseases: A Multi-Center Retrospective Study.
Time of Update: 2020-09-18
ADE2 score (median 5, range 1-15) was significantly associated with antibody-positive rates (p - 0.014), especially for neuropsychiast symptoms (p .lt;01), movement disorders (p .
-
The effect of intestinal flora and nerve inflammation, China's original new drug "Phase 9 One" International Multi-Center III clinical trial launched.
Time of Update: 2020-08-08
November 2, 2019, the National Drug Administration approved a listing application for the original new drug for Alzheimer's disease, "Phase 9 One" (Glynette Sodium, code name: GV-971), "for mild to moderate Alzheimer's disease and to improve patients' cognitive function." the development of this new AD drug is thought to be a different way, disruptive to reveal a new mechanism of anti-AD pathogenesis targeting the brain intestine axis.
